Lobbying disclosures · Lobbying report
ABT: second_quarter 2026 lobbying report
Issues related to global health policy and funding; Issues related to H.R. 8595 - National Security, Department of State, and Related Programs Appropriations Act, 2027. Issues related to global health policy and funding.
Follow ABT- Became public
- Jul 19, 2026, 3:27 PM EDT
- Event / period date
- Not stated
- Collected
- Nov 8, 2026, 9:48 AM EST
Why this is connected
Exact legal-name match: ABBOTT LABORATORIES (https://www.sec.gov/Archives/edgar/data/1800/).
Reported lobbying amounts
Income: $50,000.00
These are different reporting measures. They are not added together or treated as spending on one particular bill.
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/2c4c86d6-886f-4142-9776-831bb3a84949/","filing_uuid":"2c4c86d6-886f-4142-9776-831bb3a84949","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/2c4c86d6-886f-4142-9776-831bb3a84949/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Jonathon Jones, Partner","dt_posted":"2026-07-19T15:27:33-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"750 9th Street NW","registrant_address_2":"Suite 501","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":20744,"url":"https://lda.gov/api/v1/registrants/20744/","house_registrant_id":31587,"name":"TIBER CREEK GROUP","description":"Government Relations.","address_1":"750 9th Street NW","address_2":"Suite 501","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"GRACE BAUM","contact_telephone":"+1 202-381-6896","dt_updated":"2026-07-20T13:07:00.819992-04:00"},"client":{"id":64292,"url":"https://lda.gov/api/v1/clients/64292/","client_id":64292,"name":"ABBOTT LABORATORIES","general_description":"Medical Device and Healthcare Company.","client_government_entity":null,"client_self_select":false,"state":"IL","state_display":"Illinois","country":"US","country_display":"United States of America","ppb_state":"IL","ppb_state_display":"Illinois","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-01-01"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Issues related to global health policy and funding; Issues related to H.R. 8595 - National Security, Department of State, and Related Programs Appropriations Act, 2027.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":61401,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145802,"prefix":null,"prefix_display":null,"first_name":"NIKOLE","nickname":null,"middle_name":null,"last_name":"BURROUGHS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107259,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"KIRKLAND","last_name":"TWOMEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69921,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"LEFFINGWELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"FOR","general_issue_code_display":"Foreign Relations","description":"Issues related to global health policy and funding.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":61401,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145802,"prefix":null,"prefix_display":null,"first_name":"NIKOLE","nickname":null,"middle_name":null,"last_name":"BURROUGHS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107259,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"KIRKLAND","last_name":"TWOMEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69921,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"LEFFINGWELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in ABT
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Oct 30, 2026$1K–$15K
Rep. Thomas H. Kean, Jr. (R-NJ-7)
Sold (partial) Abbott Laboratories ABT
$1K–$15K · Traded Sep 17, 2026 · disclosed Oct 30, 2026
Committee overlap: Energy and Commerce - Oct 27, 2026$50K–$100K
Rep. Pete Sessions (R-TX-17)
$50K–$100K · Traded Oct 2, 2026 · disclosed Oct 27, 2026 · Spouse
- Oct 12, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Bought Abbott Laboratories ABT
$1K–$15K · Traded Sep 18, 2026 · disclosed Oct 12, 2026
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
Bought Abbott Laboratories ABT
$1K–$15K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Spouse
- Aug 18, 2026$15K–$50K
Rep. Rick W. Allen (R-GA-12)
$15K–$50K · Traded Jul 14, 2026 · disclosed Aug 18, 2026 · Spouse
Committee overlap: Energy and CommerceTraded 2 days before earnings - Aug 14, 2026$1K–$15K
Rep. Richard McCormick (R-GA-7)
$1K–$15K · Traded Jul 30, 2026 · disclosed Aug 14, 2026
Got $2K from the company’s PAC - Aug 12, 2026$1K–$15K
Rep. Mike Kelly (R-PA-16)
$1K–$15K · Traded Jul 17, 2026 · disclosed Aug 12, 2026 · Spouse
- Jul 21, 2026$15K–$50K
Sen. Alan Armstrong (R-OK)
Sold (full) Abbott Laboratories ABT
$15K–$50K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.